Feng Wei

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Decision Making

Small Cell Lung Cancer

Top Venues

The Journal of pathology

Cancer biology & medicine

Cell death & disease

Journal of leukocyte biology

This page only lists publications with an associated author ORCID identifier.

Publications

Weijiao Du, Fan Yang, Zhenzhen Hui, Jiali Zhang, Meng Shen, Xiubao Ren, Feng Wei
Examining the spatial distribution of tumor-infiltrating immune cells in patients with stage I to IIIA LUAD. Journal of leukocyte biology 116 (3) (2024)
Ziqing Zeng, Weijiao Du, Fan Yang, Zhenzhen Hui, Yunliang Wang, Peng Zhang, Xiying Zhang, Wenwen Yu, Xiubao Ren, Feng Wei
The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma. The Journal of pathology 262 (4) (2024)
Ziqing Zeng, Weijiao Du, Fan Yang, Zhenzhen Hui, Yunliang Wang, Peng Zhang, Xiying Zhang, Wenwen Yu, Xiubao Ren, Feng Wei
The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma. The Journal of pathology 262 (4) (2024)
Jing Qin, Feng Wei, Xiu-Bao Ren
Neutrophils in the era of single-cell RNA sequencing: functions and targeted therapies in cancer. Cancer biology & medicine 20 (12) (2024)
Weijiao Du, Fan Yang, Zhenzhen Hui, Jiali Zhang, Meng Shen, Xiubao Ren, Feng Wei
Examining the spatial distribution of tumor-infiltrating immune cells in patients with stage I to IIIA LUAD. Journal of leukocyte biology 116 (3) (2024)
Jing Qin, Feng Wei, Xiu-Bao Ren
Neutrophils in the era of single-cell RNA sequencing: functions and targeted therapies in cancer. Cancer biology & medicine 20 (12) (2024)
Ziqing Zeng, Weijiao Du, Fan Yang, Zhenzhen Hui, Yunliang Wang, Peng Zhang, Xiying Zhang, Wenwen Yu, Xiubao Ren, Feng Wei
The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma. The Journal of pathology 262 (4) (2024)
Jing Qin, Feng Wei, Xiu-Bao Ren
Neutrophils in the era of single-cell RNA sequencing: functions and targeted therapies in cancer. Cancer biology & medicine 20 (12) (2024)
Ziqing Zeng, Weijiao Du, Fan Yang, Zhenzhen Hui, Yunliang Wang, Peng Zhang, Xiying Zhang, Wenwen Yu, Xiubao Ren, Feng Wei
The spatial landscape of T cells in the microenvironment of stage III lung adenocarcinoma. The Journal of pathology (2024)
Siyu Zhu, Chen Zhang, Qian Sun, Xiubao Ren, Wenwen Yu, Feng Wei, Xiu-Bao Ren
Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD 3 +CD 56 + NKT-Like Cells. Journal of oncology 2022 (2022)
Shaochuan Liu, Yuan Meng, Liang Liu, Yingge Lv, Feng Wei, Wenwen Yu, Limei Wang, Xiying Zhang, Xiu-Bao Ren, Qian Sun
Rational pemetrexed combined with CIK therapy plus anti-PD-1 mAbs administration sequence will effectively promote the efficacy of CIK therapy in non-small cell lung cancer. Cancer gene therapy (2022)
Zhenzhen Hui, Jiali Zhang, Yulin Ren, Xiaoling Li, Cihui Yan, Wenwen Yu, Tao Wang, Shanshan Xiao, Yulong Chen, Ran Zhang, Feng Wei, Jian You, Xiu-Bao Ren
Single-cell profiling of immune cells after neoadjuvant pembrolizumab and chemotherapy in IIIA non-small cell lung cancer (NSCLC). Cell death & disease 13 (7) (2022)
Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren, Feng Wei
The prognostic landscape of genes and infiltrating immune cells in cytokine induced killer cell treated-lung squamous cell carcinoma and adenocarcinoma. Cancer biology & medicine (2021)
Qian Sun, Xiying Zhang, Limei Wang, Xujie Gao, Yanjuan Xiong, Liang Liu, Feng Wei, Lili Yang, Xiubao Ren
T-cell receptor gene therapy targeting melanoma-associated antigen-A4 by silencing of endogenous TCR inhibits tumor growth in mice and human. Cell death & disease 10 (7) (2019)
Qian Sun, Shuzhan Li, Yanan Wang, Haiyong Peng, Xiying Zhang, Yu Zheng, Chunjia Li, Li Li, Rongrong Chen, Xinxin Chen, Wenjing Bai, Xiangli Jiang, Liang Liu, Feng Wei, Boshi Wang, Yu Zhang, Hui Li, Xiubao Ren, Hongbing Zhang
Phosphoglyceric acid mutase-1 contributes to oncogenic mTOR-mediated tumor growth and confers non-small cell lung cancer patients with poor prognosis. Cell death and differentiation 25 (6) (2018)